Alexander J Mackay
Overview
Explore the profile of Alexander J Mackay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Finney L, Mah J, Duvall M, Wiseman D, Kamal F, Fenwick P, et al.
Am J Respir Crit Care Med
. 2025 Mar;
PMID: 40043205
Rationale: Recovery from chronic obstructive pulmonary disease (COPD) exacerbations is heterogeneous and has a profound impact on disease trajectories. Resolution of airway inflammation is an active process which may be...
2.
Tatarchuk S, Choueiri R, Mackay A, Johnston S, Cooper W, Snyder K, et al.
Chemphyschem
. 2024 Feb;
25(8):e202300889.
PMID: 38316612
Developing electrocatalysts for urea oxidation reaction (UOR) works toward sustainably treating urea-enriched water. Without a clear understanding of how UOR products form, advancing catalyst performance is currently hindered. This work...
3.
Raherison-Semjen C, Mezzi K, Kostikas K, Mackay A, Singh D
Int J Chron Obstruct Pulmon Dis
. 2021 Apr;
16:901-907.
PMID: 33833510
Objective: To evaluate the perception of physicians on gender-specific differences in the diagnosis of chronic obstructive pulmonary disease (COPD) using a qualitative and anonymous questionnaire-based survey. Methods: The survey was...
4.
Kostikas K, Mackay A, Vogelmeier C, Frent S, Gupta P, Banerji D, et al.
Int J Chron Obstruct Pulmon Dis
. 2020 Sep;
15:1831-1838.
PMID: 32884253
Background: Chronic obstructive pulmonary disease (COPD) exacerbations are difficult outcomes to measure in clinical trials. It would be valuable to be able to predict which patients are likely to benefit...
5.
Mackay A, Kostikas K, Roche N, Frent S, Olsson P, Pfister P, et al.
Respir Res
. 2020 Apr;
21(1):93.
PMID: 32321518
Background: COPD is a heterogeneous disease and patients may respond differently to therapies depending on baseline symptom burden. Methods: This post-hoc analysis from the 52-week FLAME study investigated the impact...
6.
Cook N, Gey J, Oezel B, Mackay A, Kumari C, Kaur V, et al.
Int J Chron Obstruct Pulmon Dis
. 2019 Aug;
14:1365-1376.
PMID: 31417250
Qualitative research provides real-life information on patients' condition and facilitates informed design of future clinical studies. We used Online Communities as a qualitative research tool to evaluate the effect of...
7.
Kostikas K, Greulich T, Mackay A, Lossi N, Aalamian-Mattheis M, Nunez X, et al.
ERJ Open Res
. 2019 Mar;
5(1).
PMID: 30815470
The association between clinically relevant changes in patient-reported outcomes (PROs) and forced expiratory volume in 1 s (FEV) in patients with chronic obstructive pulmonary disease (COPD) has rarely been investigated....
8.
Thomson R, Aung N, Sanghvi M, Paiva J, Lee A, Zemrak F, et al.
PLoS One
. 2018 Mar;
13(3):e0194434.
PMID: 29558496
Background: Reduced lung function is common and associated with increased cardiovascular morbidity and mortality, even in asymptomatic individuals without diagnosed respiratory disease. Previous studies have identified relationships between lung function...
9.
Westwood J, Mackay A, Donaldson G, Machin S, Wedzicha J, Scully M
ERJ Open Res
. 2017 Jan;
2(4.
PMID: 28053974
http://ow.ly/ZaPj303xxPf.
10.
Brill S, Patel A, Singh R, Mackay A, Brown J, Hurst J
Respir Res
. 2015 Apr;
16:16.
PMID: 25849856
Background: Exacerbations of non-cystic fibrosis bronchiectasis cause significant morbidity but there are few detailed data on their clinical course and associated physiological changes. The biology of an exacerbation has not...